JPMorgan Amends Exact Sciences Stake as of Dec 29, 2023

TL;DR

**JPMorgan Chase & Co. updated its stake in Exact Sciences Corp. as of December 29, 2023.**

AI Summary

JPMorgan Chase & Co. filed an amended Schedule 13G/A on January 23, 2024, indicating a change in their beneficial ownership of Exact Sciences Corp. common stock as of December 29, 2023. This filing, an amendment to a previous disclosure, signals that JPMorgan Chase & Co. continues to hold a significant, though potentially altered, stake in Exact Sciences Corp. For investors, this matters because large institutional holdings can influence stock stability and signal confidence (or lack thereof) in the company's future prospects.

Why It Matters

This filing shows that a major financial institution, JPMorgan Chase & Co., is actively managing its investment in Exact Sciences Corp., which can impact market perception and trading activity.

Risk Assessment

Risk Level: low — This is a routine amendment filing by a large institutional investor, indicating ongoing portfolio management rather than a sudden, drastic change.

Analyst Insight

Investors should note that a major institution like JPMorgan Chase & Co. is actively managing its position in Exact Sciences Corp. and consider this as part of their broader due diligence, but this filing alone doesn't signal a strong buy or sell.

Key Players & Entities

• JPMorgan Chase & Co. (company) — the entity filing the SC 13G/A, reporting beneficial ownership
• Exact Sciences Corp. (company) — the subject company whose securities are being reported
• December 29, 2023 (date) — the date of the event requiring the filing
• January 23, 2024 (date) — the filing date of the SC 13G/A
• $0.01 (dollar_amount) — par value per share of Exact Sciences Corp. common stock

Forward-Looking Statements

• JPMorgan Chase & Co. will continue to be a significant institutional holder of Exact Sciences Corp. stock. (JPMorgan Chase & Co.) — high confidence, target: Next 12 months

FAQ

From the Filing

0000019617-24-000120.txt : 20240123 0000019617-24-000120.hdr.sgml : 20240123 20240123094030 ACCESSION NUMBER: 0000019617-24-000120 CONFORMED SUBMISSION TYPE: SC 13G/A CONFIRMING COPY: PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240123 DATE AS OF CHANGE: 20240123 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62447 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JPMORGAN CHASE & CO CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] ORGANIZATION NAME: 02 Finance IRS NUMBER: 132624428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 383 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 MAIL ADDRESS: STREET 1: 383 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: J P MORGAN CHASE & CO DATE OF NAME CHANGE: 20010102 FORMER COMPANY: FORMER CONFORMED NAME: CHASE MANHATTAN CORP /DE/ DATE OF NAME CHANGE: 19960402 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL BANKING CORP DATE OF NAME CHANGE: 19920703 SC 13G/A 1 EXACT_SCIENCES_CORPORATION.htm FILING EXACT SCIENCES CORPORATION Schedule 13G   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G     Under the Securities Exchange Act of 1934 (Amendment No. 01 )*   EXACT SCIENCES CORPORATION   (Name of Issuer)   Common Stock, $0.01 par value per share (Title of Class of Securities)   30063P105 (CUSIP Number)   December 29, 2023 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:        x  Rule 13d-1(b)        o  Rule 13d-1(c)        o  Rule 13d-1(d)   * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.   The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).           CUSIP No.  30063P105                           1   NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)   JPMORGAN CHASE & CO. 13-2624428       2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)   (a)   o   (b)   o       3   SEC USE ONLY               4   CITIZENSHIP OR PLACE OF ORGANIZATION       Delaware         NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH:  5   SOLE VOTING POWER       16,348,081       6   SHARED VOTING POWER       10,068       7   SOLE DISPOS